Hemodialysis Market

Hemodialysis Market Outlook (2023 to 2033)

Expanding at a CAGR of 4.5%, the global hemodialysis market is predicted to increase from a valuation of US$ 96.54 billion in 2023 to US$ 149.92 billion by 2033-end.

Hemodialysis is a procedure in which the blood is purified using a dialyzer, sometimes known as an artificial kidney, and a dialysis machine. Blood pressure and important blood minerals such as salt, potassium, and calcium are both controlled by hemodialysis.

Demand for hemodialysis is expected to be driven by several factors, including the increasing prevalence of acute kidney injury (AKI), technological advancements, a lack of organ donors, the risks associated with transplants, and initiatives by the major players to introduce cutting-edge products and services.

The COVID-19 pandemic has increased the need for dialysis significantly around the world. As a result, the industry is experiencing significant financial incentives and regulatory support from several government agencies across the globe. During the projected period, these factors are anticipated to boost the hemodialysis market growth.

Hemodialysis products are segmented into services, drugs, consumables, and equipment. Global demand for hemodialysis services is expected to increase at a CAGR of 5% during the forecast period.

Growing importance of contemporary renal care facilities for both emergency and chronic treatment, as well as the growing focus placed by service providers on giving patients high-quality care, is boosting the demand for hemodialysis services. Additionally, as a result of the service providers' improved business models, which are profit- and patient-focused, the sales of hemodialysis services are rising.

• For instance, DaVita introduced a telehealth system called DaVita Care Connect in February 2021 for its home dialysis company. It was merely one of the several connected technologies that were included in its service offering to enhance the therapy and results for patients who choose to self-manage at home.

Sales of hemodialysis consumables are expected to expand at a healthy rate during the forecast period. Consumables are further segmented into bloodlines, concentrates, and catheters. During the forecast period, it is anticipated that substantial initiatives made by respective governments to improve patient safety, patient-centred care, and efficacy will increase demand for hemodialysis consumables.

Catheters are being produced using high-tech materials that are impervious to chemicals such as alcohol, peroxide, and iodine. Reducing the likelihood of malfunctioning will increase the life of catheters. Antimicrobial-coated catheters are also becoming increasingly popular, which reduces the incidence of bloodstream infections.

Thus, all the above-mentioned aspects are expected to increase the sales of hemodialysis consumables during the forecast period.

Report Attributes	Details
Hemodialysis Market Size (2023E)	US$ 96.54 Billion
Forecasted Market Value (2033F)	US$ 149.92 Billion
Global Market Growth Rate (2023 to 2033)	4.5% CAGR
China Market Growth Rate (2023 to 2033)	7% CAGR
Japan Market Growth Rate (2023 to 2033)	3% CAGR
Germany Market Growth Rate (2023 to 2033)	3% CAGR
Canada Market Growth Rate (2023 to 2033)	4% CAGR
Key Companies Profiled	Argon Medical Devices, Inc. Asahi Kasei Medical Co., Ltd. B. Braun Melsungen AG BARD, A Becton, Dickinson Company Baxter International, Inc. DaVita Healthcare Partners, Inc. Fresenius Medical Care AG & Co. KgaA Kawasumi Laboratories, Inc. Medical Components, Inc. Merit Medical Systems, Inc. Nikkiso Co., Ltd. Nipro Corporation Teleflex, Inc.

Which Opportunities Await Suppliers of Hemodialysis Equipment?

“Adverse Health Effects of COVID-19 Driving Demand for Hemodialysis Procedures”

According to Fact.MR, a market research and competitive intelligence provider, the hemodialysis market is expected to see healthy growth after post COVID-19 pandemic period. Because of the pandemic's high hospitalization rates, the demand for kidney dialysis equipment and supplies has increased drastically. It was discovered that those who contracted the COVID-19 virus developed kidney ailments and other chronic conditions.

• For instance, it has been recognised that those infected with COVID-19 showed signs of kidney damage, and even those with no prior kidney problems were infected with the kidney disease, according to an article titled “COVID-19 Impact on Patients with Kidney Disease” published by Johns Hopkins University in March 2022.

“Growing Burden of Chronic Kidney Disorders”

The market for hemodialysis is projected to increase due to the patients' rising risk of having chronic renal disorders and acute kidney damage, as well as rising rates of diabetes and hypertension in the population.

• For instance, one in ten adults is estimated to have chronic kidney disease (CKD), according to estimations from the 2020 report of the International Society of Nephrology (ISN), which also stated that renal illness impacted almost 850 million people worldwide in 2020.
• The same source also estimates that by 2040, chronic kidney disease (CKD) would rank as the fifth most prevalent cause of death worldwide.

“Rising Prevalence of Diabetes & Hypertension”

Rising risk of acquiring renal disease and kidney failure can be attributed to the rising prevalence of diabetes and hypertension in the population. A common side effect of both type 1 and type 2 diabetes is diabetic nephropathy. This condition affects the kidney's blood vessel clusters, which are responsible for filtering the body's waste and may be harmed by high blood glucose levels.

For instance, according to the statistics published by the International Diabetes Federation in 2021,

• Around 61 million cases of diabetes were observed in Europe, 97 million in MEA, 51 million in North America & Caribbean, and 296 million in Asia Pacific.
• In 2020, around 27.5 million people in Nigeria were living with hypertension, according to a study that appeared in the Clinical Hypertension Journal in February 2021 and was titled “Prevalence, Awareness, Treatment, and Control of Hypertension in Nigeria in 1995 and 2020: A Systematic Analysis of Current Evidence”.

Diabetes and hypertension affect the kidneys by narrowing the arteries and limiting blood flow to the kidneys, which further increases the cases of chronic kidney disorders. Thus, such conditions are boosting the demand for hemodialysis equipment.

Which Obstacles Need to Be Tackled By Manufacturers of Hemodialysis Systems?

“High Treatment Costs and Lack of Understanding about Advanced Hemodialysis Equipment”

Continuous development in the hemodialysis market encourages innovation, which leads to the creation of sophisticated systems that patients and clinicians are finding difficult to adapt to. The only way to get beyond this obstacle is by providing instructional training and introducing devices that are simple to handle.

Another factor that may hamper the sales of hemodialysis equipment during the forecast period is the high cost of the treatment. Due to the high cost of the therapy and the need for frequent sessions, dialysis burdens many patients financially. A kidney transplant or dialysis treatment places a heavy financial burden on the majority of people in middle-income countries.

Country-wise Analysis

What is the Demand Outlook for Hemodialysis Services in the United States?

“Increasing Prevalence of Chronic Kidney Disorders and Presence of Advanced Healthcare Facilities”

The United States currently holds a significant share of the North American market. The dominance can be attributed to the factors such as increasing cases of chronic kidney disorders due to the prevalence of hypertension and diabetes, availability of well-established healthcare infrastructure, and rising spending power on healthcare.

• According to data from the Centers for Disease Control and Prevention's chronic kidney disease in the United States 2021 report, it has been found that in the United States, people 65 years of age and older have a high prevalence of chronic kidney disease (38%), followed by those between the ages of 45 and 64 (12%), and those between the ages of 18 and 44 (6%).

Furthermore, the growing rate of elderly population in the nation is more likely to experience chronic renal illnesses, diabetes, and hypertension, which further is expected to boost sales growth over the projection period.

• For instance, according to the 2022 statistics published by the United Nations Population Fund, in the United States, 17% of the population is aged 65 years and above.

Why are Sales of Hemodialysis Equipment Increasing Rapidly in Germany?

“Cost-effectiveness of Treatment Procedures”

Demand for hemodialysis equipment in the Germany market is increasing due to the government's efforts to provide affordable treatments and the exponential growth in the rate of dialysis facilities. The growing older population, which has higher incidences of diabetes, is another factor that favourably influences the growth of the market for hemodialysis.

• In Germany, the prevalence of end-stage kidney disease is around 1000 patients per million population, as per a study by Oxford Academic.

What is Supporting Product Sales Growth in China & Japan?

“Rapidly Rising Senior Population and Introduction of Advanced Technologies”

The rapidly growing rate of the senior population in China and Japan is supporting the sales of hemodialysis systems. The ageing population is at higher risk of experiencing kidney-related disorders.

• The prevalence of chronic kidney disorders is rising rapidly in Japan, more than 2000 people per million population are living with CKDs, according to National Center for Biotechnology Information.

Also, the Chinese government is launching various programs and adopting several efforts to raise awareness of acute kidney injuries and other kidney-related disorders. Furthermore, the rapid growth of the healthcare sector and the introduction of automated diagnostic tools are encouraging the sales of hemodialysis systems in these countries.

Category-wise Analysis

Why are Conventional Long-term Hemodialysis Systems Highly Preferred?

“Advancements in On-door Operational Services”

Based on modality, the hemodialysis systems are segmented into conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis.

The increasing rate of patients with chronic kidney diseases, growing business activities in advancing hemodialysis systems, and widespread acceptance of hemodialysis therapy over peritoneal dialysis among patients with chronic kidney diseases (CKD) and end-stage renal diseases (ESRD) are some of the reasons driving the demand for conventional long-term hemodialysis systems.

• NephroPlus introduced its Dialysis on Call service in Hyderabad (India) in July 2021. This new service allows patients to receive dialysis at their convenience by providing the necessary equipment to them. The benefit of the service is that there is no requirement for the machine and other equipment to be situated in the patient's house.
• In partnership with NephroPlus, Max Healthcare's Max@Home service introduced home hemodialysis treatments for patients in June 2021.
• In addition, the Organ Procurement and Transplantation Network (February 2022) states that over 92,000 Americans needed kidney transplants.
• According to the same source, 25,490 individuals, or around 1 in 5 were able to have kidney transplants in the United States in 2021.

As a result, the population's demand for hemodialysis is rising due to the lack of available kidneys for transplant. Thus, such aspects are fuelling market growth.

Competitive Landscape

The market is anticipated to be driven by leading manufacturers' efforts to produce specialized dialysis equipment as well as expanding alliances and collaboration among industry participants. Some of the key players in the hemodialysis market are collaborating with regional participants to expand their product offerings, and for that, they are constantly working on pricing trends, local supply chain management systems, and product quality standards.

Some New Developments

• For instance, after getting FDA marketing approval, Medtronic introduced its Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the United States in December 2020. The Cincinnati Children's Hospital Medical Center received the first machine.
• To answer the unmet technological needs of the rising dialysis sector, Diality invested roughly US$ 12.5 million in creating a portable hemodialysis device in October 2020.
• Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. entered into a ground-breaking partnership in October 2020 to enhance the quality of life and outcomes for individuals with end-stage chronic kidney disease by raising optimal dialysis starts and providing earlier analysis of transplantation and home dialysis options.

Key Segments of Hemodialysis Industry Research

• By Product :

  • Services
  • Drugs
  • Consumables
  • Equipment

• By Modality :

  • Conventional Long-term Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis

• By End User :

  • Dialysis Centers
  • Hospitals
  • Home Care Settings

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA